96 related articles for article (PubMed ID: 3019219)
41. Overexpression of cell cycle regulatory proteins correlates with advanced tumor stage in head and neck squamous cell carcinomas.
Nguyen DC; Parsa B; Close A; Magnusson B; Crowe DL; Sinha UK
Int J Oncol; 2003 Jun; 22(6):1285-90. PubMed ID: 12738995
[TBL] [Abstract][Full Text] [Related]
42. Expression of KIT (CD117) in neoplasms of the head and neck: an ancillary marker for adenoid cystic carcinoma.
Mino M; Pilch BZ; Faquin WC
Mod Pathol; 2003 Dec; 16(12):1224-31. PubMed ID: 14681323
[TBL] [Abstract][Full Text] [Related]
43. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.
Fenic I; Steger K; Gruber C; Arens C; Woenckhaus J
Oncol Rep; 2007 Jul; 18(1):253-9. PubMed ID: 17549376
[TBL] [Abstract][Full Text] [Related]
44. Amplification of wild-type K-ras promotes growth of head and neck squamous cell carcinoma.
Hoa M; Davis SL; Ames SJ; Spanjaard RA
Cancer Res; 2002 Dec; 62(24):7154-6. PubMed ID: 12499248
[TBL] [Abstract][Full Text] [Related]
45. Immunohistochemical study of c-fos-positive lymphocytes infiltrated into human squamous cell carcinomas of the head and neck during radiation therapy and its clinical significance.
Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2301-7. PubMed ID: 9815628
[TBL] [Abstract][Full Text] [Related]
46. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
[TBL] [Abstract][Full Text] [Related]
47. beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck.
Yu Z; Weinberger PM; Provost E; Haffty BG; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
Clin Cancer Res; 2005 Apr; 11(7):2471-7. PubMed ID: 15814622
[TBL] [Abstract][Full Text] [Related]
48. [Squamous cell carcinoma antigen. Current clinical value of a new tumor marker in head and neck cancer; preliminary results of a prospective study after 12 months].
Clasen B; Roettger D; Senekowitsch R; Menz E
Laryngol Rhinol Otol (Stuttg); 1988 Aug; 67(8):420-5. PubMed ID: 3210877
[TBL] [Abstract][Full Text] [Related]
49. L-myc polymorphism in head and neck nonmelanoma skin and lower lip cancers.
Gözü A; Ergen A; Dayicioglu D; Yaylim I; Ozsoy Z; Isbir T
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):725-8. PubMed ID: 18645122
[TBL] [Abstract][Full Text] [Related]
50. Expression of oncogenes in human tumours with special reference to the head and neck region.
Field JK; Spandidos DA
J Oral Pathol; 1987 Mar; 16(3):97-107. PubMed ID: 3040947
[TBL] [Abstract][Full Text] [Related]
51. Coamplification of the hst and bcl-1 oncogenes in advanced squamous cell carcinomas of the head and neck.
Volling P; Jungehülsing M; Jücker M; Stützer H; Diehl V; Tesch H
Eur J Cancer; 1993; 29A(3):383-9. PubMed ID: 8398339
[TBL] [Abstract][Full Text] [Related]
52. Analysis of gene amplification in head-and-neck squamous-cell carcinoma.
Leonard JH; Kearsley JH; Chenevix-Trench G; Hayward NK
Int J Cancer; 1991 Jun; 48(4):511-5. PubMed ID: 2045198
[TBL] [Abstract][Full Text] [Related]
53. Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck.
Field JK
Eur J Cancer B Oral Oncol; 1992 Jul; 28B(1):67-76. PubMed ID: 1330149
[TBL] [Abstract][Full Text] [Related]
54. c-myc oncogene copy number in squamous carcinoma of the head and neck.
Haughey BH; von Hoff DD; Windle BE; Wahl GM; Mock PM
Am J Otolaryngol; 1992; 13(3):168-71. PubMed ID: 1626617
[TBL] [Abstract][Full Text] [Related]
55. Expression of c-erbB2 and c-myc in squamous epithelia and squamous cell carcinomas of the head and neck and the lower female genital tract.
Riviére A; Wilckens C; Löning T
J Oral Pathol Med; 1990 Oct; 19(9):408-13. PubMed ID: 2269935
[TBL] [Abstract][Full Text] [Related]
56. Immunohistochemical detection of the H-ras, K-ras, and N-ras oncogenes in squamous cell carcinoma of the head and neck.
McDonald JS; Jones H; Pavelic ZP; Pavelic LJ; Stambrook PJ; Gluckman JL
J Oral Pathol Med; 1994 Sep; 23(8):342-6. PubMed ID: 7815372
[TBL] [Abstract][Full Text] [Related]
57. MYC amplification in squamous cell carcinomas of the head and neck.
Rodrigo JP; Lazo PS; Ramos S; Alvarez I; Suárez C
Arch Otolaryngol Head Neck Surg; 1996 May; 122(5):504-7. PubMed ID: 8615967
[TBL] [Abstract][Full Text] [Related]
58. Mechanisms of C-myc oncogenic activity in head and neck squamous cell carcinoma.
Mastronikolis N; Ragos V; Kyrodimos E; Chrysovergis A; Papanikolaou V; Mastronikolis S; Stamatelopoulos A; Tsiambas E
J BUON; 2019; 24(6):2242-2244. PubMed ID: 31983089
[TBL] [Abstract][Full Text] [Related]
59. Genomic profile of a squamous cell carcinoma ex pleomorphic adenoma compared to a head and neck squamous cell carcinoma.
Mariano FV; Saccomani LFV; Giovanetti K; Del Negro A; Kowalski LP; Krepischi ACV; Altemani A
Braz J Otorhinolaryngol; 2018; 84(3):393-397. PubMed ID: 26971044
[No Abstract] [Full Text] [Related]
60. Changes in expression of oncogenes and TP53 tumour suppressor gene as biomarkers in head and neck cancers.
Szanyi I; Bauer M; Gerlinger I; Járai T; Gobel G; Lujber L; Szabadi E; Fehér K; Émber A; Ember I; Kiss I
Eur Arch Otorhinolaryngol; 2011 Jul; 268(7):1041-6. PubMed ID: 21120662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
